XML 92 R66.htm IDEA: XBRL DOCUMENT v3.23.4
Note 9 - Other Disclosures - Options Granted (Details)
€ / shares in Units, € in Thousands
12 Months Ended
Dec. 31, 2022
EUR (€)
€ / shares
Dec. 31, 2021
EUR (€)
€ / shares
Dec. 31, 2020
EUR (€)
Jan. 01, 2022
Statement Line Items [Line Items]        
Number of options 1,562,977 1,805,100 0  
Number of share options exercised in share-based payment arrangement 242,123 (0)    
Weighted average fair value at grant date (EUR) (in EUR per share) | € / shares € 19.26 € 19.26    
Increase in equity (kEUR) € 1,447 € 1,981 € 32,160  
Number of share options outstanding in share-based payment arrangement at end of period 1,562,977 1,805,100 0  
Conversion stock option program (CSOP) [member]        
Statement Line Items [Line Items]        
Number of options   1,805,100   1,805,100
Number of share options outstanding in share-based payment arrangement at end of period   1,805,100   1,805,100
Share options1 [member]        
Statement Line Items [Line Items]        
Expense of the period (kEUR) € 652 € 1,898    
Increase in equity (kEUR) € 652 € 1,898